Increased Risk of Radioiodine Treatment Failure Associated with Graves Disease Refractory to Methimazole.
Kwak JJ, Altoos R, Jensen A, Altoos B, McDermott MT. Increased Risk of Radioiodine Treatment Failure Associated with Graves Disease Refractory to Methimazole. Endocr Pract. 2020 Nov; 26(11):1312-1319.